Přihlásit se Zaregistrujte se zdarma

Výnosy R/R společnosti Theratechnologies

Jaká je hodnota metriky Výnosy R/R společnosti Theratechnologies?

Hodnota metriky Výnosy R/R společnosti Theratechnologies, Inc. je 25.47%

Jaká je definice metriky Výnosy R/R?

Čtvrtletní růst výnosů (Revenue Q / Q) z roku na rok je nárůst příjmů firmy ve srovnání s výsledky v korespondujícího čtvrtletí minulého roku vyjádřeného v procentech.

Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.

Výnosy R/R společností v sektoru Health Care sektor na TSX ve srovnání se společností Theratechnologies

Čemu se věnuje společnost Theratechnologies?

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Firmy s metrikou výnosy r/r podobnou společnosti Theratechnologies